Form D · Other Technology
A28 Therapeutics, Inc.
La Jolla, CA · CIK 0002051843
Offering snapshot reported Jan 14, 2025 · SEC filing
- Reported sold
- $1.9M Offering amount: $1.9M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 1, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 14, 2025 | Initial | $1,900,000 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-535069
Source: Form D, filed Jan 14, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ross Barrett | Director |
| Stanley Lewis | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
7660 Fay Avenue H829
La Jolla, CA, 92037
La Jolla, CA, 92037